Ricevi più risposte dai datori di lavoro
Invia un CV specifico per questa offerta in pochi minuti.
LSC Lifesciences Consultants in Milan is seeking an Associate Strategy Consultant to join a fast-growing, international team focused on Biopharma and MedTech. You will perform analyses, translate data into insights, and contribute to client recommendations across diverse projects.
The role offers onboarding and training, exposure to senior leadership, and opportunities for accelerated promotion within a merit-based growth path in a global life sciences consultancy.
Fast-track your strategy career on a global stage with LSC Lifesciences Consultants. We’re recruiting Associate Strategy Consultants to fuel our next wave of international growth. At LSC you’ll step onto a merit-based, accelerated career path, gain hands‑on experience across diverse project types, and tackle the toughest strategic questions facing Biopharma and MedTech innovators worldwide. As an Associate you’ll sit at the heart of each project team—working side‑by‑side with senior leaders and engaging directly with C‑suite life‑sciences executives—while your contributions help shape the therapies of tomorrow.
You will also take part in our onboarding and training program, designed to quickly build your understanding of the Healthcare and Life Sciences market and accelerate your growth within the firm.
We are seeking motivated, strategic thinkers with a passion for Life Sciences and an interest in strategy consulting, who are eager to combine science and business. Ideal candidates are problem‑solvers with entrepreneurial drive and the ability to work in a dynamic, international environment.
To learn more about LSC and our recruitment process, please visit:
Website
LSC is a global life sciences‑focused commercial strategy consultancy with a 20‑year track record of helping Large and Small Cap Biopharma, MedTech, and Diagnostics clients to successfully deliver to market transformative healthcare products and patient‑centric solutions in the US, Europe, and Emerging Markets.